The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States

1. KefauverE

1965

In a few hands

Harmondsworth

Penguin

2. FroudJJohalSLeaverAWilliamsK

2006

Financialization and strategy: narrative and numbers

London and New York

Routledge

3. General Accounting Office

2002

Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations.

Available: http://www.gao.gov/new.items/d03177.pdf. Accessed 27 November 2007

4. IMS Health

2005

Total U.S. promotional spend by type, 2004.

Accessed 4 November 2006 at http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_49695992_75406357,00.html

5. Pharmaceutical Research and Manufacturers of America

2006

Pharmaceutical industry profile 2006.

Available: http://www.phrma.org/files/2006%20Industry%20Profile.pdf. Accessed 27 November 2007

6. HensleySMartinezB

2005 July 15

To sell their drugs, companies increasingly rely on doctors.

Wall Street Journal

A1

7. Quintiles Transnational

2001

Promoting drugs through physician meetings and events: Pfizer leads the way; antidepressants are top category.

Accessed 3 March 2002 at http://www.quintiles.com/products_and_services/informatics/scott_levin/press_releases/press_release/1,1254,209,00.html

8. La PumaJSeltzerJ

2002

Phase IV market steams ahead.

CenterWatch

9

1, 9-13

9. LauzonL-PHasbaniM

2006

Analyse socio-économique: industrie pharmaceutique mondiale pour la période de dix ans 1996–2005

Montreal

Chaire d'études socio-économiques de l'UQAM

10. CAM Group

2005

Total U.S. promotional activity for 2004. CAM USA Newsletter.

Accessed 22 July 2007 at http://csd.cam-group.com/www_assets/pages/downloads/USNewsletterQ404.pdf

11. IMS Health

2006

Channel distribution by U.S. sales.

Available: http://www.imshealth.com/ims/portal/front/articleC/0,2777,6652_80408863_80411875,00.htm. Accessed 28 November 2007

12. IMS Health

2006

Global pharmaceutical sales, 1999–2006.

Available: http://www.imshealth.com/ims/portal/front/articleC/0,2777,6652_80528184_80528202,00.html. Accessed 27 November 2007

13. CAM Group

2005

4th quarter 2004 promotional activity. CAM Group News.

Accessed 22 July 2007 at http://csd.cam-group.com/www_assets/pages/downloads/CAMNewsletterQ404.pdf

14. IMS Health

2004

Total U.S. value of free product samples, 2004.

Accessed 4 November 2006 at http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_78152267_78152297,00.html

15. National Science Foundation

2006

U.S. industrial R&D performers report increased expenditures for 2004.

Available: http://www.nsf.gov/statistics/infbrief/nsf07304/#notes. Accessed 27 November 2007

16. GøtzschePCHróbjartssonAJohansenHKHaahrMTAltmanDG

2007

Ghost authorship in industry-initiated randomised trials.

PLoS Med

4

e19

doi:10.1371/journal.pmed.0040019

17. SteinmanMABeroLAChrenMMLandefeldCS

2006

Narrative review: the promotion of gabapentin: an analysis of internal industry documents.

Ann Intern Med

145

284

293

18. GencarelliDM

2005

One pill, many prices: variation in prescription drug prices in selected government programs. National Health Policy Forum.

Available: http://www.nhpf.org/pdfs_ib/IB807_DrugPricing_08-29-05.pdf. Accessed 27 November 2007

19. Pharmaceutical Research and Manufacturers of America

2005

America's pharmaceutical companies increase Katrina donations; more than $100 million in medicines, cash donated so far.

Available: http://www.liberty-page.com/issues/comparison/pharm.html. Accessed 27 November 2007

20. Organization for Economic Cooperation and Development

2006

OECD health data 2006. Organization for Economic Cooperation and Development.

21. IMS Health

2004

U.S. purchase activity by channel, 2004.

Accessed 4 November 2006 at http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_49695983_69891354,00.html

22. AngellM

2004

The truth about the drug companies: how they deceive us and what to do about it

New York

Random House

23. Office of Technology Assessment

1993

Pharmaceutical R&D: costs, risks and rewards

Washington (D. C.)

US Government Printing Office

24. JacobzoneS

2000

Pharmaceutical policies in OECD countries: reconciling social and industrial goals

Paris

OECD Publishing

Available: http://ideas.repec.org/p/oec/elsaaa/40-en.html. Accessed 28 November 2007

25. Consumers International

2006

Branding the cure: a consumer perspective on corporate social responsibility, drug promotion and the pharmaceutical industry in Europe

London

Consumers International

26. Centers for Medicare and Medicaid Services

2003

Health care industry market update: pharmaceuticals.

Available: http://www.fdcpa.com/CMS%20Pharmaceuticals%20Jan%202003.pdf. Accessed 28 November 2007

27. Families USA

2002

Profiting from pain: where prescription drug dollars go.

Available: http://www.familiesusa.org/assets/pdfs/PPreport89a5.pdf. Accessed 28 November 2007.2.254